Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001708599-25-000071

Chief Scientific Officer sold 6,500 shares at $5.01 ($32,565)

  • Chief Scientific Officer acquired 6,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Moreadith Randall Chief Scientific Officer 2025-07-14 Option exercise +6,500 $0.06 $390 6,500 D
Moreadith Randall Chief Scientific Officer 2025-07-14 Sale −6,500 $5.01 $32,565 0 D
Derivatives
Moreadith Randall Chief Scientific Officer 2025-07-14 Option exercise · Stock Option (right to buy) −6,500 501,686 D
Open-market sales · 6,500 sh · avg $5.01 · $32,565
Loading xslF345X05/wk-form4_1752763244.xml…